Published in Folia Biol (Praha) on January 01, 1999
Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD? Inflamm Res (2009) 0.85
Head and neck squamous cancer stromal fibroblasts produce growth factors influencing phenotype of normal human keratinocytes. Histochem Cell Biol (2009) 0.85
Nuclear presence of adhesion-/growth-regulatory galectins in normal/malignant cells of squamous epithelial origin. Histochem Cell Biol (2005) 0.80
Diagnostic relevance of Langerin detection in cells from bronchoalveolar lavage of patients with pulmonary Langerhans cell histiocytosis, sarcoidosis and idiopathic pulmonary fibrosis. Virchows Arch (2004) 0.77
Comparative phenotypic characterization of keratinocytes originating from hair follicles. J Mol Histol (2005) 0.75
Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J Immunol (1980) 6.69
New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates. Biochemistry (1979) 5.02
Chemical synthesis of a polypeptide predicted from nucleotide sequence allows detection of a new retroviral gene product. Nature (1980) 4.35
Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc Natl Acad Sci U S A (1981) 4.26
Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem (1982) 3.95
Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol (2000) 3.54
Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci U S A (1996) 2.85
Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem (1981) 2.80
Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol (2000) 2.40
Probing of the receptor-binding sites of the H1 and H3 influenza A and influenza B virus hemagglutinins by synthetic and natural sialosides. Virology (1993) 2.27
Regulation of mast cell survival by IgE. Immunity (2001) 2.11
Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol (2000) 2.06
Benign metastasizing leiomyoma of the uterus: documentation of clinical, immunohistochemical and lectin-histochemical data of ten cases. Virchows Arch (2000) 1.97
Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology (1997) 1.80
Relationship between tissue plasminogen activator and the activators in blood and vascular wall. Thromb Res (1980) 1.76
Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. J Exp Med (2001) 1.74
Secretion of leukotriene C and other arachidonic acid metabolites by macrophages challenged with immunoglobulin E immune complexes. J Exp Med (1982) 1.73
An RNA ligase from wheat germ which participates in transfer RNA splicing in vitro. J Biol Chem (1983) 1.70
Effects of host-dependent glycosylation of hemagglutinin on receptor-binding properties on H1N1 human influenza A virus grown in MDCK cells and in embryonated eggs. Virology (1998) 1.60
Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol (1996) 1.58
IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells. J Exp Med (1983) 1.56
Biochemical and biophysical characterization of human recombinant IgE-binding protein, an S-type animal lectin. J Biol Chem (1992) 1.49
[Lectin-related use of mistletoe: an experimental form of treatment with preclinically demonstrated potential risks]. Dtsch Med Wochenschr (2002) 1.48
Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int J Cancer (1999) 1.46
Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus. Nature (1981) 1.45
Postreassortment changes in influenza A virus hemagglutinin restoring HA-NA functional match. Virology (1998) 1.42
Galectins in cell growth and apoptosis. Cell Mol Life Sci (2003) 1.41
[Immunomodulating mistletoe therapy by lectin standardization: a double-edged sword?]. Versicherungsmedizin (1999) 1.41
Dendritic cells and their role in skin-induced immune responses. J Eur Acad Dermatol Venereol (2001) 1.39
[Interstitial pulmonary processes]. Cas Lek Cesk (2002) 1.39
Purification and partial characterization of plasminogen activator from human uterine tissue. Biochim Biophys Acta (1979) 1.38
Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Mol Med (1995) 1.38
Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression. Cancer (1999) 1.38
A human lectin, galectin-3 (epsilon bp/Mac-2), stimulates superoxide production by neutrophils. J Immunol (1995) 1.35
Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. J Biol Chem (1982) 1.35
Isolation and characterization of human VkIII germ-line genes. Implications for the molecular basis of human VkIII light chain diversity. J Immunol (1987) 1.35
Acceleration of fibrinolysis by high-frequency ultrasound: the contribution of acoustic streaming and temperature rise. Thromb Res (2000) 1.35
H5N1 chicken influenza viruses display a high binding affinity for Neu5Acalpha2-3Galbeta1-4(6-HSO3)GlcNAc-containing receptors. Virology (2004) 1.34
Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer (2000) 1.33
Surface expression of functional IgE binding protein, an endogenous lectin, on mast cells and macrophages. J Immunol (1992) 1.32
Human T lymphotropic virus-I infection of human T lymphocytes induces expression of the beta-galactoside-binding lectin, galectin-3. Am J Pathol (1996) 1.30
Superficial accumulation of plasminogen during plasma clot lysis. Circulation (1995) 1.30
Receptor for the cell binding site of discoidin I. Cell (1985) 1.28
The amino-acid sequence of the abalone (Haliotis laevigata) nacre protein perlucin. Detection of a functional C-type lectin domain with galactose/mannose specificity. Eur J Biochem (2000) 1.26
Differences between HA receptor-binding sites of avian influenza viruses isolated from Laridae and Anatidae. Avian Dis (2003) 1.26
Differences between influenza virus receptors on target cells of duck and chicken and receptor specificity of the 1997 H5N1 chicken and human influenza viruses from Hong Kong. Avian Dis (2003) 1.26
Genetic basis for the cross-reactive idiotypes on the light chains of human IgM anti-IgG autoantibodies. Proc Natl Acad Sci U S A (1986) 1.24
The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest (1985) 1.22
Plant lectins: occurrence, biochemistry, functions and applications. Glycoconj J (2001) 1.22
Silver staining of nucleolar granules in tumor cells. Cancer Res (1979) 1.20
Photochemistry of cytosine derivatives. 1. Photochemistry of thymidylyl-(3' leads to 5')-deoxycytidine. Biochemistry (1978) 1.19
A clonal analysis of the IgE response and its implications with regard to isotope commitment. J Exp Med (1981) 1.18
Antifibrotic effects of matrine on in vitro and in vivo models of liver fibrosis in rats. Acta Pharmacol Sin (2001) 1.18
Quantitation of tissue-type plasminogen activator in human endothelial cell cultures by use of an enzyme immunoassay. Thromb Res (1984) 1.18
Epsilon BP, a beta-galactoside-binding animal lectin, recognizes IgE receptor (Fc epsilon RI) and activates mast cells. Biochemistry (1993) 1.18
Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1). Thromb Haemost (1988) 1.17
Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro. Thromb Haemost (1981) 1.17
Immunological characterization of plasminogen activator activities in human tissues and body fluids. J Lab Clin Med (1981) 1.17
Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathol (2001) 1.17
Production of plasminogen activators and inhibitor by serially propagated endothelial cells from adult human blood vessels. Arteriosclerosis (1987) 1.16
Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J Biol Chem (2001) 1.14
Identification of an IgE-binding protein by molecular cloning. Proc Natl Acad Sci U S A (1985) 1.13
Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells. Blood (2001) 1.13
Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B. J Clin Invest (2001) 1.13
Rearrangements of the fibrin network and spatial distribution of fibrinolytic components during plasma clot lysis. Study with confocal microscopy. J Biol Chem (1996) 1.12
Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cells. J Biol Chem (1988) 1.12
Eukaryotic glycosylation: whim of nature or multipurpose tool? Cell Mol Life Sci (1999) 1.12
Preclinical evaluation of docetaxel (Taxotere). Semin Oncol (1995) 1.11
Increased secretion of tumor necrosis factors alpha, interleukin 1, and interleukin 6 by human mononuclear cells exposed to beta-galactoside-specific lectin from clinically applied mistletoe extract. Cancer Res (1990) 1.11
Binding of tissue-type plasminogen activator by the mannose receptor. J Biol Chem (1991) 1.10
Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice. FASEB J (2001) 1.09
Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells. Virology (1999) 1.09
Human IgE-binding protein: a soluble lectin exhibiting a highly conserved interspecies sequence and differential recognition of IgE glycoforms. Biochemistry (1990) 1.09
Survival, disease-free interval, and associated tumor features in patients with colon/rectal carcinomas and their resected intra-pulmonary metastases. Eur J Cardiothorac Surg (2001) 1.09
Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression. Int J Cancer (2000) 1.08
Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma. Hum Pathol (1996) 1.08
Structural organization of procaryotic and eucaryotic Hsp90. Influence of divalent cations on structure and function. J Biol Chem (1995) 1.07
Differences in zero-force and force-driven kinetics of ligand dissociation from beta-galactoside-specific proteins (plant and animal lectins, immunoglobulin G) monitored by plasmon resonance and dynamic single molecule force microscopy. Arch Biochem Biophys (2000) 1.06
Carbohydrate composition and immunomodulatory activity of different glycoforms of alpha1-acid glycoprotein. Glycoconj J (1997) 1.06
A further contribution to the demonstration of RNA and nucleoli of blood cells in smear preparations. Folia Haematol Int Mag Klin Morphol Blutforsch (1969) 1.06
An IgE-binding protein with a distinctive repetitive sequence and homology with an IgG receptor. Proc Natl Acad Sci U S A (1987) 1.05
Ultrastructural aspects of the ribonucleo-protein network in nuclei of Walker tumor and rat liver. Exp Cell Res (1967) 1.05
Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2. J Immunol (1987) 1.05
Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas. Histopathology (2008) 1.05
Proteins C23 and B23 are the major nucleolar silver staining proteins. Life Sci (1979) 1.04
GlycoChip: multiarray for the study of carbohydrate-binding proteins. Lab Chip (2003) 1.04
Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. Cancer Res (1995) 1.03
Wedgelike glycodendrimers as inhibitors of binding of mammalian galectins to glycoproteins, lactose maxiclusters, and cell surface glycoconjugates. Chembiochem (2001) 1.02
Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas. Eur J Cancer (1994) 1.02
Synthetic polymeric sialoside inhibitors of influenza virus receptor-binding activity. FEBS Lett (1990) 1.01
Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients. Cancer Res (1989) 1.01
The effect of flow on lysis of plasma clots in a plasma environment. Thromb Haemost (2000) 1.01
Decreased expression of galectin-3 is associated with progression of human breast cancer. J Pathol (1996) 1.01